The Ohio State University Wexner Medical Center on Wednesday randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
UK trade group slams Novo, Novartis, Pfizer and Otsuka for code breaches
A British watchdog has criticized four drugmakers, including Novo Nordisk, for violating the Association of the British Pharmaceutical Industry’s code of practice, marking the third